PMLS Virtual Series 2022 – Precision Medicine Outside of Oncology

On Demand Now Click Here

March 29, 2022

As with many successful paradigm shifts, precision medicine has been adopted in other therapeutic, diagnostic, and analytical areas. Each area has its own intrinsic needs, but all share commonalities that allow the precision medicine paradigm to be taken up by these new areas.  Of particular interest in this regard has been how one therapeutic area can inform development in another therapeutic area – e.g., how precision data can be used to find that a target for one disease may turn out to be an effective target for another disease, or a drug for one condition may turn out to be effective in another disease.  In brief, as each therapeutic area is developed, the body of knowledge in precision medicine will be enhanced, resulting in the surprising development of novel precision medicines.

Please join us for the Precision Medicine Outside Oncology Summit to learn about this growth of precision medicine into new medical applications and marketplaces from leaders in biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies.

Among the topics to be discussed

  • Therapeutic areas that have adopted the precision medicine paradigm
  • Informatics, Analytics, Signal and Image Processing
  • Genetics/Genomics Technology
  • Proteomics/Protein-based Assays
  • Emerging ‘Omics Diagnostics
  • Gene and Protein Biomarkers
  • Augmented Intelligence – empowering algorithms in drug development, diagnostic analysis, and clinical trial design
  • Partnerships among clinical laboratories, imaging technology developers, pharmas, payers, and CROs – the technological, medical, and economic ecosystem to better healthcare

Who should attend:

  • Clinicians, pathologists, histologists, diagnostics developers, AI and system software designers, payers, research scientists, or in regulatory affairs
  • Executives and Decision Makers – CEOs, CFOs, CTOs, CMOs, and CSOs
  • Payers and Insurers
  • Medical and Pharmacy Directors
  • Employer and Retiree Benefits Analysts
  • Research, Development, and Practicing Clinicians
  • Diagnostics Developers
  • Diagnostics Licensing, Sales, and Planning
  • Regulatory Leaders in Government and Business Affairs groups
  • Economic Planners and Forecasters
  • Marketing Leaders
  • Systems Developers for Systems and Software
  • Artificial and Augmented Intelligence Developers
  • Emerging ‘Omics Diagnostics in Genetics/Genomics, Proteomics/Protein-based Assays
  • Imaging label developers
  • Biomarker Research Scientists and Developers
  • Imaging platforms
  • Artificial/Augmented Intelligence, Informatics, Analytics, Signal and Image Processing